226 related articles for article (PubMed ID: 18272501)
1. Ganglioside GM2/GM3 complex affixed on silica nanospheres strongly inhibits cell motility through CD82/cMet-mediated pathway.
Todeschini AR; Dos Santos JN; Handa K; Hakomori SI
Proc Natl Acad Sci U S A; 2008 Feb; 105(6):1925-30. PubMed ID: 18272501
[TBL] [Abstract][Full Text] [Related]
2. Ganglioside GM2-tetraspanin CD82 complex inhibits met and its cross-talk with integrins, providing a basis for control of cell motility through glycosynapse.
Todeschini AR; Dos Santos JN; Handa K; Hakomori SI
J Biol Chem; 2007 Mar; 282(11):8123-33. PubMed ID: 17215249
[TBL] [Abstract][Full Text] [Related]
3. Synergistic inhibition of cell migration by tetraspanin CD82 and gangliosides occurs via the EGFR or cMet-activated Pl3K/Akt signalling pathway.
Li Y; Huang X; Zhang J; Li Y; Ma K
Int J Biochem Cell Biol; 2013 Nov; 45(11):2349-58. PubMed ID: 23968914
[TBL] [Abstract][Full Text] [Related]
4. GM2/GM3 controls the organizational status of CD82/Met microdomains: further studies in GM2/GM3 complexation.
Santos RCM; Lucena DMS; Loponte HFBR; Alisson-Silva F; Dias WB; Lins RD; Todeschini AR
Glycoconj J; 2022 Oct; 39(5):653-661. PubMed ID: 35536494
[TBL] [Abstract][Full Text] [Related]
5. Gangliosides and CD82 inhibit the motility of colon cancer by downregulating the phosphorylation of EGFR at different tyrosine sites and signaling pathways.
Huang X; Li Y; He X; Chen Y; Wei W; Yang X; Ma K
Mol Med Rep; 2020 Nov; 22(5):3994-4002. PubMed ID: 33000220
[TBL] [Abstract][Full Text] [Related]
6. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9.
Mitsuzuka K; Handa K; Satoh M; Arai Y; Hakomori S
J Biol Chem; 2005 Oct; 280(42):35545-53. PubMed ID: 16103120
[TBL] [Abstract][Full Text] [Related]
7. Ganglioside GM3 promotes HGF-stimulated motility of murine hepatoma cell through enhanced phosphorylation of cMet at specific tyrosine sites and PI3K/Akt-mediated migration signaling.
Li Y; Huang X; Zhong W; Zhang J; Ma K
Mol Cell Biochem; 2013 Oct; 382(1-2):83-92. PubMed ID: 23749170
[TBL] [Abstract][Full Text] [Related]
8. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
[TBL] [Abstract][Full Text] [Related]
9. Suppression of epidermal growth factor receptor signaling by protein kinase C-alpha activation requires CD82, caveolin-1, and ganglioside.
Wang XQ; Yan Q; Sun P; Liu JW; Go L; McDaniel SM; Paller AS
Cancer Res; 2007 Oct; 67(20):9986-95. PubMed ID: 17942932
[TBL] [Abstract][Full Text] [Related]
10. Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional alpha3, alpha5-CD82 glycosylation complex in ldlD 14 cells.
Ono M; Handa K; Withers DA; Hakomori S
Biochem Biophys Res Commun; 2000 Dec; 279(3):744-50. PubMed ID: 11162423
[TBL] [Abstract][Full Text] [Related]
11. CD82 blocks cMet activation and overcomes hepatocyte growth factor effects on oligodendrocyte precursor differentiation.
Mela A; Goldman JE
J Neurosci; 2013 May; 33(18):7952-60. PubMed ID: 23637186
[TBL] [Abstract][Full Text] [Related]
12. Increased Expression of Simple Ganglioside Species GM2 and GM3 Detected by MALDI Imaging Mass Spectrometry in a Combined Rat Model of Aβ Toxicity and Stroke.
Caughlin S; Hepburn JD; Park DH; Jurcic K; Yeung KK; Cechetto DF; Whitehead SN
PLoS One; 2015; 10(6):e0130364. PubMed ID: 26086081
[TBL] [Abstract][Full Text] [Related]
13. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases.
Sridhar SC; Miranti CK
Oncogene; 2006 Apr; 25(16):2367-78. PubMed ID: 16331263
[TBL] [Abstract][Full Text] [Related]
14. Regulation of c-Met signaling by the tetraspanin KAI-1/CD82 affects cancer cell migration.
Takahashi M; Sugiura T; Abe M; Ishii K; Shirasuna K
Int J Cancer; 2007 Nov; 121(9):1919-1929. PubMed ID: 17621632
[TBL] [Abstract][Full Text] [Related]
15. Tetraspanin CD9 is a "proteolipid," and its interaction with alpha 3 integrin in microdomain is promoted by GM3 ganglioside, leading to inhibition of laminin-5-dependent cell motility.
Kawakami Y; Kawakami K; Steelant WF; Ono M; Baek RC; Handa K; Withers DA; Hakomori S
J Biol Chem; 2002 Sep; 277(37):34349-58. PubMed ID: 12068006
[TBL] [Abstract][Full Text] [Related]
16. Multimodal detection of GM2 and GM3 lipid species in the brain of mucopolysaccharidosis type II mouse by serial imaging mass spectrometry and immunohistochemistry.
Dufresne M; Guneysu D; Patterson NH; Marcinkiewicz MM; Regina A; Demeule M; Chaurand P
Anal Bioanal Chem; 2017 Feb; 409(5):1425-1433. PubMed ID: 27873002
[TBL] [Abstract][Full Text] [Related]
17. Gangliosides GM1, GM2 and GM3 inhibit the platelet-derived growth factor-induced signalling transduction pathway in vascular smooth muscle cells by different mechanisms.
Sachinidis A; Kraus R; Seul C; Meyer zu Brickwedde MK; Schulte K; Ko Y; Hoppe J; Vetter H
Eur J Cell Biol; 1996 Sep; 71(1):79-88. PubMed ID: 8884181
[TBL] [Abstract][Full Text] [Related]
18. Cell adhesion, spreading, and motility of GM3-expressing cells based on glycolipid-glycolipid interaction.
Kojima N; Hakomori S
J Biol Chem; 1991 Sep; 266(26):17552-8. PubMed ID: 1894638
[TBL] [Abstract][Full Text] [Related]
19. Glycosynaptic microdomains controlling tumor cell phenotype through alteration of cell growth, adhesion, and motility.
Hakomori SI
FEBS Lett; 2010 May; 584(9):1901-6. PubMed ID: 19874824
[TBL] [Abstract][Full Text] [Related]
20. Effect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptor.
Toledo MS; Suzuki E; Handa K; Hakomori S
J Biol Chem; 2005 Apr; 280(16):16227-34. PubMed ID: 15710618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]